the first commercially available matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometer to feature orthogonal geometry and collisional cooling. The technology, ...
The basic mass spectrometer measures an ion's mass-to-charge (m/z ... the 4700 Proteomics Analyzer made by Applied Biosystems of Foster City, Calif., which features a MALDI (matrix-assisted laser ...
Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...
Hosted on MSN11mon
MALDI-TOF Mass Spectrometry in the BiosciencesMALDI refers specifically to the ionization or desorption method that is used to introduce the analyte into the spectrometer. One of the most common mass spectrometry ionization techniques is ...
A new study has revealed the pivotal role of theanine, a unique amino acid, in the early growth and development of tea ...
Eastern Kentucky University (EKU) received a Major Research Instrumentation (MRI) award of $381,870 from the National Science ...
Matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) mass spectrometry has become an important tool in the life sciences. Recently, mass spectrometry methods have ...
Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.
You have full access to this article via your institution. One our aims is the molecular analysis and imaging of peptides and proteins in brain tumors, specifically in human glioblastoma.
Download this infographic to learn more about the structural biology research field and the use of cross-linking mass spectrometry in this space. Mass spectrometers are an integral component of ...
Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results